Page last updated: 2024-09-03

rc 3095 and Precancerous Conditions

rc 3095 has been researched along with Precancerous Conditions in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kozacko, MF; Liebow, C; Mang, TS; Priore, RL; Schally, AV	1

Other Studies

1 other study(ies) available for rc 3095 and Precancerous Conditions

Article	Year
Bombesin antagonist prevents CO2 laser-induced promotion of oral cancer. Proceedings of the National Academy of Sciences of the United States of America, 1996, Apr-02, Volume: 93, Issue:7 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Bombesin; Cricetinae; Dihematoporphyrin Ether; Lasers; Mouth Neoplasms; Neoplasms, Radiation-Induced; Peptide Fragments; Precancerous Conditions; Time Factors	1996

Article

Year

Bombesin antagonist prevents CO2 laser-induced promotion of oral cancer.

Proceedings of the National Academy of Sciences of the United States of America, 1996, Apr-02, Volume: 93, Issue:7

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Bombesin; Cricetinae; Dihematoporphyrin Ether; Lasers; Mouth Neoplasms; Neoplasms, Radiation-Induced; Peptide Fragments; Precancerous Conditions; Time Factors

1996